The markets extended its losses during the midday with the Dow plunging 178 points to 17,669 as crude oil prices continued to tumble. Nasdaq plummeted 53 points to 5,088.
On the upside
XBiotech (Nasdaq: XBIT) reported positive results from its European Phase III clinical study of its colorectal cancer treatment Xilonix .
Bargain hunters lifted shares of e-Future Information Technology (Nasdaq: EFUT).
Arrowhead Research (Nasdaq: ARWR) presented upbeat data for its hepatitis B treatment ARC-520 at the HEP DART 2015 conference.
On the downside
Shares of Breitburn Energy Partners (Nasdaq: BBEP) continued falling.
Agios Pharmaceuticals (Nasdaq:AGIO) will present data from an ongoing Phase 1 study of AG-120 and an ongoing Phase 1/2 study of AG-221 at the 2015 American Society of Hematology Annual Meeting and Exposition this week.
TheStreet recommended selling Energy Transfer Equity (NYSE: ETE).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 plunged 21 points to 2,069. Bitcoin added $1 to $391.